Who is sponsoring NCT06629792?

NCT06629792 is sponsored by Revision Skincare.

What condition does NCT06629792 study?

NCT06629792 studies Fine Lines, Wrinkles, Laxity; Skin.

What drugs are being tested in NCT06629792?

Interventions: Gentle Cleanser, Facial Moisturizer, sunscreen SPF 30.

What is the status of NCT06629792?

NCT06629792 is currently COMPLETED.

Last reviewed 2024-10-08 · How we verify

A Clinical Study Evaluating the Efficacy and Tolerability of a Topical Facial Treatment For Facial Rejuvenation

NCT06629792 NA COMPLETED

This single-center clinical trial was conducted to evaluate the efficacy and tolerability of a topical facial treatment when applied by a license esthetician in clinic in a series of 3 sessions with 1 month intervals, in combination with a cleanser, moisturizer, and sunscreen over the course of 12 weeks in healthy women aged 35 to 60 with mild to moderate global facial fine lines, wrinkles, and laxity. Thirty-two (32) healthy female subjects completed the clinical study.

Details

Lead sponsor	Revision Skincare
Phase	NA
Status	COMPLETED
Enrolment	32
Start date	Tue Jan 11 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Thu May 05 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Fine Lines
Wrinkles
Laxity; Skin

Interventions

Gentle Cleanser
Facial Moisturizer
sunscreen SPF 30

Countries

United States